Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine derivatives as novel selective Axl inhibitors

被引：7

作者：

Inoue, Satoshi ^{[1
]}

Yamane, Yoshinobu ^{[1
]}

Tsukamoto, Shuntaro ^{[2
]}

Murai, Norio ^{[1
]}

Azuma, Hiroshi ^{[1
]}

Nagao, Satoshi ^{[1
]}

Nishibata, Kyoko ^{[2
]}

Fukushima, Sayo ^{[2
]}

Ichikawa, Kenji ^{[2
]}

Nakagawa, Takayuki ^{[2
]}

Sugi, Naoko Hata ^{[2
]}

Ito, Daisuke ^{[2
]}

Kato, Yu ^{[2
]}

Goto, Aya ^{[3
]}

Kakiuchi, Dai ^{[3
]}

Ueno, Takashi ^{[4
]}

Matsui, Junji ^{[2
]}

Matsushima, Tomohiro ^{[1
]}

机构：

[1] Eisai & Co Ltd, Tsukuba Res Labs, Med Chem, 5-1-3 Tokodai, Tsukuba, Ibaraki 3002635, Japan

[2] Eisai & Co Ltd, Tsukuba Res Labs, Biopharmacol, 5-1-3 Tokodai, Tsukuba, Ibaraki 3002635, Japan

[3] Eisai & Co Ltd, Tsukuba Res Labs, Drug Safety, 5-1-3 Tokodai, Tsukuba, Ibaraki 3002635, Japan

[4] Eisai & Co Ltd, Tsukuba Res Labs, Drug Metab & Pharmacokinet, 5-1-3 Tokodai, Tsukuba, Ibaraki 3002635, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2021年 / 48卷

关键词：

Axl; Mer; Structure-activity relationships; Cancer; Inhibitor; Small molecule; CANCER-CELLS; RESISTANCE; OVEREXPRESSION; THERAPY;

D O I：

10.1016/j.bmcl.2021.128247

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Axl and Mer are members of the TAM (Tyro3-Axl-Mer) family of receptor tyrosine kinases. Previously, we reported that enzyme-mediated inhibition of Mer by an Axl/Mer dual inhibitor led to retinal toxicity in mice, whereas selective Axl inhibition by compound 1 did not. On the other hand, compound 1 showed low membrane permeability. Here, we designed and synthesized a novel series of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine derivatives and evaluated their Axl and Mer inhibitory activities, leading to identification of ER-001259851-000 as a potent and selective Axl inhibitor with drug-likeness and a promising pharmacokinetic profile in mice.

引用

页数：7

共 50 条

[41] SYNTHESIS OF 2,6-DISUBSTITUTED 4-HYDROXY-5,6,7,8-TETRAHYDROPYRIDO[4,3-D]PYRIMIDINES
KRETZSCHMAR, E
MEISEL, P
PHARMAZIE, 1988, 43 (07): : 475 - 476
[42] SYNTHESIS AND ANTINEOPLASTIC EFFECTS OF FURO[3,4-D]PYRIMIDINE DERIVATIVES
MACHON, Z
CIEPLIK, J
POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY, 1988, 40 (02): : 201 - 208
[43] Synthesis of some novel pyrazolo[3,4-d]pyrimidine derivatives as potential antimicrobial agents
Holla, BS
Mahalinga, M
Karthikeyan, MS
Akberali, PM
Shetty, NS
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (06) : 2040 - 2047
[44] An unequivocal synthesis of 4-amino-1,5,6,8-tetrahydropyrido[2,3-d]pyrimidine-2,7-diones and 2-amino-3,5,6,8-tetrahydropyrido[2,3-d]pyrimidine-4,7-diones
Borrell, JI
Teixido, J
MartinezTeipel, B
Serra, B
Matallana, JL
Costa, M
Batllori, X
COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 1996, 61 (06) : 901 - 909
[45] NEW, GENERAL SYNTHESIS OF PYRAZOLO[3,4-D]-PYRIMIDINE DERIVATIVES
YONEDA, F
NAGAMATS.T
SYNTHESIS-STUTTGART, 1973, (05): : 300 - 301
[46] QSAR Study of Some Pyrazolo[3,4-d]pyrimidine Derivatives as the c-Src Inhibitors
Shukla, Bindesh Kumar
Yadava, Umesh
INTERNATIONAL CONFERENCE ON CONDENSED MATTER AND APPLIED PHYSICS (ICC 2015), 2016, 1728
[47] Structure/Activity Analysis of TASK-3 Channel Antagonists Based on a 5,6,7,8 tetrahydropyrido[4,3-d]pyrimidine
Ramirez, David
Bedoya, Mauricio
Kiper, Aytug K.
Rinne, Susanne
Morales-Navarro, Samuel
Hernandez-Rodriguez, Erix W.
Sepulveda, Francisco V.
Decher, Niels
Gonzalez, Wendy
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
[48] STRUCTURE OF THIOPURINOL (PYRAZOLO[3,4-D]PYRIMIDINE-4-THIOL OR 5H-PYRAZOLO[3,4-D]PYRIMIDINE-4-THIONE AND THEIR THIO DERIVATIVES
THANG, KV
OLIVIER, JL
COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES SERIE C, 1969, 268 (20): : 1798 - &
[49] Synthesis and evaluation of novel pyrazolo[3,4-d] pyrimidine derivatives as selective adenosine A2A receptor antagonists.
Stratton, GC
Lerpiniere, J
Gaur, S
Weiss, SM
Knight, TR
Misra, A
Jones, J
Lawrence, A
Benwell, K
Upton, R
Dourish, CT
Cliffe, IA
Gillespie, RJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U52 - U52
[50] Novel Tetrahydropyrido[3,4-d]pyrimidines as HPK1 Inhibitors for Treating Cancer, Inflammatory, and Autoimmune Diseases
Sabnis, Ram W.
ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (03): : 318 - 319

← 1 2 3 4 5 →